Effect of tranexamic acid and indirect factor Xa inhibitor on blood loss and DVT after TKA .
Less blood loss under concomitant administration of tranexamic acid and indirect factor Xa inhibitor following total knee arthroplasty: a prospective randomized controlled trial
Knee Surg Sports Traumatol Arthrosc. 2013 Nov;21(11):2611-772 patients scheduled to receive primary unilateral cemented total knee arthroplasty (TKA) were randomly assigned into one of two groups to determine if the simultaneous application of tranexamic acid and indirect factor Xa inhibitor was a safe and effective blood loss prevention treatment when compared to indirect factor Xa inhibitor alone. Patients either received tranexamic acid in combination with indirect factor Xa inhibitor, or a placebo in combination with indirect factor Xa inhibitor, and were followed-up for 90 days after surgery. The results of the study indicated that tranexamic acid significantly reduced acute blood loss in patients following TKA surgery, and that no apparent adverse effects arose from the possible drug interaction between the two interventions.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
